chr12-49040065-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_003482.4(KMT2D):​c.7705G>A​(p.Gly2569Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000461 in 1,613,918 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0026 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00024 ( 1 hom. )

Consequence

KMT2D
NM_003482.4 missense

Scores

2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:3O:1

Conservation

PhyloP100: 0.428

Publications

5 publications found
Variant links:
Genes affected
KMT2D (HGNC:7133): (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]
KMT2D Gene-Disease associations (from GenCC):
  • choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Illumina, G2P
  • Kabuki syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • branchial arch abnormalities, choanal atresia, athelia, hearing loss, and hypothyroidism syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Kabuki syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0052972436).
BP6
Variant 12-49040065-C-T is Benign according to our data. Variant chr12-49040065-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 134697.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00258 (393/152336) while in subpopulation AFR AF = 0.00892 (371/41584). AF 95% confidence interval is 0.00817. There are 1 homozygotes in GnomAd4. There are 183 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 393 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KMT2DNM_003482.4 linkc.7705G>A p.Gly2569Ser missense_variant Exon 32 of 55 ENST00000301067.12 NP_003473.3 O14686-1Q59FG6Q6PIA1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KMT2DENST00000301067.12 linkc.7705G>A p.Gly2569Ser missense_variant Exon 32 of 55 5 NM_003482.4 ENSP00000301067.7 O14686-1

Frequencies

GnomAD3 genomes
AF:
0.00255
AC:
388
AN:
152218
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00883
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000981
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000628
AC:
156
AN:
248228
AF XY:
0.000467
show subpopulations
Gnomad AFR exome
AF:
0.00884
Gnomad AMR exome
AF:
0.000348
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000557
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000267
Gnomad OTH exome
AF:
0.000332
GnomAD4 exome
AF:
0.000240
AC:
351
AN:
1461582
Hom.:
1
Cov.:
32
AF XY:
0.000208
AC XY:
151
AN XY:
727068
show subpopulations
African (AFR)
AF:
0.00824
AC:
276
AN:
33478
American (AMR)
AF:
0.000403
AC:
18
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26130
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86242
European-Finnish (FIN)
AF:
0.0000375
AC:
2
AN:
53378
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000207
AC:
23
AN:
1111816
Other (OTH)
AF:
0.000381
AC:
23
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
26
52
78
104
130
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00258
AC:
393
AN:
152336
Hom.:
1
Cov.:
33
AF XY:
0.00246
AC XY:
183
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.00892
AC:
371
AN:
41584
American (AMR)
AF:
0.000980
AC:
15
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68020
Other (OTH)
AF:
0.00142
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
20
40
61
81
101
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000734
Hom.:
0
Bravo
AF:
0.00271
ESP6500AA
AF:
0.00522
AC:
20
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000712
AC:
86
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:3Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Kabuki syndrome 1 Uncertain:2
Nov 01, 2016
Center for Human Genetics, Inc, Center for Human Genetics, Inc
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 03, 2018
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KMT2D NM_003482.3 exon 31 p.Gly2569Ser (c.7705G>A):This variant has not been reported in the literature but is present in 0.9% (217/24088) of African alleles, including 1 homozygote in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/12-49433848-C-T). This variant is present in ClinVar (Variation ID: 134697). This variant amino acid Serine (Ser) is present in several species; this suggests that this variant may not impact the protein. Computational predictive tools also suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

not specified Benign:1Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Jun 16, 2017
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome;CN030661:Kabuki syndrome 1 Uncertain:1
-
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KMT2D NM_003482.3 exon 31 p.Gly2569Ser (c.7705G>A):This variant has not been reported in the literature but is present in 0.9% (217/24088) of African alleles, including 1 homozygote in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/12-49433848-C-T). This variant is present in ClinVar (Variation ID: 134697). This variant amino acid Serine (Ser) is present in several species; this suggests that this variant may not impact the protein. Computational predictive tools also suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

Kabuki syndrome Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Mar 26, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 30459467) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
17
DANN
Benign
0.88
DEOGEN2
Benign
0.055
T
Eigen
Benign
-0.61
Eigen_PC
Benign
-0.51
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.71
T
M_CAP
Uncertain
0.15
D
MetaRNN
Benign
0.0053
T
MetaSVM
Benign
-0.76
T
MutationAssessor
Benign
0.34
N
PhyloP100
0.43
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-2.1
N
REVEL
Benign
0.21
Sift
Uncertain
0.0040
D
Polyphen
0.0020
B
Vest4
0.17
MVP
0.27
MPC
0.17
ClinPred
0.016
T
GERP RS
3.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1
Varity_R
0.11
gMVP
0.21
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201507971; hg19: chr12-49433848; COSMIC: COSV56455112; COSMIC: COSV56455112; API